BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 10377916)

  • 21. Clinical experience with cyclooxygenase-2 inhibitors.
    Lanas A
    Rheumatology (Oxford); 2002 Apr; 41 Supp 1():16-22; discussion 35-42. PubMed ID: 12173276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How may quality of life for rheumatoid arthritis patients be enhanced by current and future treatments?
    Fries JF
    Rheumatology (Oxford); 1999 Nov; 38 Suppl 2():35-40. PubMed ID: 10646489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NSAID alternatives.
    Med Lett Drugs Ther; 2005 Jan; 47(1200):8. PubMed ID: 15647706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New treatment of pain and fever in rheumatoid arthritis and arthrosis. The first cyclooxygenase-2 inhibitors show promising results].
    Oliw E; Wollheim FA
    Lakartidningen; 2000 Jun; 97(24):2942-4. PubMed ID: 10900877
    [No Abstract]   [Full Text] [Related]  

  • 25. Diagnosis and management of rheumatoid arthritis.
    Rindfleisch JA; Muller D
    Am Fam Physician; 2005 Sep; 72(6):1037-47. PubMed ID: 16190501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update in rheumatoid arthritis therapy.
    Kim-Howard XR; Staudt L; James JA
    J Okla State Med Assoc; 2005 Feb; 98(2):53-62. PubMed ID: 15789642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rheumatic disease in the elderly: rheumatoid arthritis.
    Tutuncu Z; Kavanaugh A
    Rheum Dis Clin North Am; 2007 Feb; 33(1):57-70. PubMed ID: 17367692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cox-2 inhibitors: a new class of medication?
    Habershaw TA
    Med Health R I; 1999 Sep; 82(9):332-4. PubMed ID: 10517079
    [No Abstract]   [Full Text] [Related]  

  • 29. Management of early rheumatoid arthritis.
    Suresh E
    J Assoc Physicians India; 2007 May; 55():355-62. PubMed ID: 17844697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An evidence-based approach to prescribing nonsteroidal antiinflammatory drugs. Third Canadian Consensus Conference.
    Tannenbaum H; Bombardier C; Davis P; Russell AS;
    J Rheumatol; 2006 Jan; 33(1):140-57. PubMed ID: 16331802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inclusion of glucocorticoids in recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: Comment on the article by Saag et al.
    van Tuyl LH; Lems WF; Voskuyl AE; Dijkmans BA; Boers M; Kerstens PJ
    Arthritis Rheum; 2009 Jan; 61(1):141-2; author reply 141-2. PubMed ID: 19116962
    [No Abstract]   [Full Text] [Related]  

  • 32. Coverage inequalities of new therapies for rheumatoid arthritis in a managed care setting.
    Gallup E
    Manag Care Interface; 2001 Jul; 14(7):52-4, 57-8, 69. PubMed ID: 11481817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disease-modifying antirheumatic drugs in rheumatoid arthritis: current concepts.
    Emery P; Luqmani R; Gordon C
    Br J Clin Pract; 1994; 48(2):82-6. PubMed ID: 7912952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A cross-sectional retrospective assessment of anti-arthritic drugs in patients with arthritis in Korea.
    Lee MC; Lee S; Suh DC; Kim J; Kong SX;
    Curr Med Res Opin; 2003; 19(7):597-602. PubMed ID: 14606981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management pattern for patients with osteoarthritis treated with traditional non-steroidal anti-inflammatory drugs in Spain prior to introduction of Coxibs.
    Arboleya LR; de la Figuera E; Soledad García M; Aragón B;
    Curr Med Res Opin; 2003; 19(4):278-87. PubMed ID: 12841920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Forthcoming non-steroidal anti-inflammatory drugs: are they really devoid of side effects?
    Bjarnason I
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S27-36. PubMed ID: 10379467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An evidence-based approach to prescribing NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis: The Second Canadian Consensus Conference.
    Tannenbaum H; Peloso PM; Russell AS; Marlow B
    Can J Clin Pharmacol; 2000; 7 Suppl A():4A-16A. PubMed ID: 11011110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rheumatoid arthritis and the older adult.
    Ignatavicius DD
    Geriatr Nurs; 2001; 22(3):139-42. PubMed ID: 11410765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Celebrex: confirmed effectiveness and safety (new data)].
    Nasonov EL
    Ter Arkh; 2001; 73(5):57-61. PubMed ID: 11517753
    [No Abstract]   [Full Text] [Related]  

  • 40. COX-2 inhibitors: new drugs for the management of pain and inflammation.
    Hutchins V; Hutchins B
    Dent Today; 2001 Feb; 20(2):56-61. PubMed ID: 12524847
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.